A prospective national precision medicine trial evaluating the feasibility of blood-based molecular profiling in patients with Cancer of Unknown Primary (CUP-COMP)
Alicia‐Marie Conway, M. Robinson, Matthew Concannon, Sally Clive et autres
gb (code pays fourni par la source)
0 citations
British Journal of Cancer